Heart device patients may soon get full-body MRI scans without worry

NCT ID NCT06038123

Completed Disease control Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether Medtronic SureScan pacemakers and defibrillators are safe during 3.0T MRI scans anywhere on the body. 64 adults with these devices received an MRI scan and were followed for one month. The goal was to see if any serious problems occurred, such as device malfunction or heart rhythm issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Medtronic SureScan CIED system (pacemaker or defibrillator)
What this could lead to: If successful, this could confirm that people with these heart devices can safely undergo 3.0T MRI scans without restrictions on which body part is scanned.
What could go wrong: This is a small, completed study with only 64 participants. Results may not apply to all patients or other device brands. MRI-related risks like device malfunction or heart rhythm issues remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bradycardia heart failure Tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRADYCARDIA HEART FAILURE TACHYCARDIA

Contacts and locations

Locations

Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China
Nanfang Hospital Southern Medical University

Guangzhou, Guangdong, China
Shanghai Tongren Hospital

Shanghai, Shanghai Municipality, China
Shanxi Cardiovascular Hospital

Taiyuan, Shanxi, China
The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.